Adjuvant Holdings Co (TSE:4929) EV-to-EBITDA: 14.66 (As of Aug. 31, 2026) — Near Median

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:4929 Adjuvant Holdings Co Ltd TSE:4929
59 GF Score
Price 円741.00
GF Value 円730.77
Valuation Fairly Valued
! 2 Warning Signs
View Full Analysis

What is Adjuvant Holdings Co EV-to-EBITDA?

Adjuvant Holdings Co TSE:4929 -0.13% 59 EV-to-EBITDA is 14.66 as of Aug. 31, 2026, which is 7% below its 10-year median of 15.74. GuruFocus rates TSE:4929 with a GF Score™ of 59/100 and a GF Value™ of 円730.77 (Fairly Valued). The stock has 2 warning signs investors should review. Among 1,655 Consumer Packaged Goods companies, Adjuvant Holdings Co ranks worse than 71.18% on this metric.

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Adjuvant Holdings Co's enterprise value is 円3,816 Mil. Adjuvant Holdings Co's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 was 円260 Mil. Therefore, Adjuvant Holdings Co's EV-to-EBITDA for today is 14.66.

The historical rank and industry rank for Adjuvant Holdings Co's EV-to-EBITDA or its related term are showing as below:

TSE:4929' s EV-to-EBITDA Range Over the Past 10 Years
Min: -183.5   Med: 15.74   Max: 40.94
Current: 14.66

During the past 13 years, the highest EV-to-EBITDA of Adjuvant Holdings Co was 40.94. The lowest was -183.50. And the median was 15.74.

TSE:4929's EV-to-EBITDA is ranked worse than
71.18% of 1655 companies
in the Consumer Packaged Goods industry
Industry Median: 9.31 vs TSE:4929: 14.66

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2026-08-31), Adjuvant Holdings Co's stock price is 円741.00. Adjuvant Holdings Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was 円17.860. Therefore, Adjuvant Holdings Co's PE Ratio (TTM) for today is 41.49.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio (TTM).


Adjuvant Holdings Co  (TSE:4929) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

Adjuvant Holdings Co's PE Ratio (TTM) for today is calculated as:

PE Ratio (TTM)=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=741.00/17.860
=41.49

Adjuvant Holdings Co's share price for today is 円741.00.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Adjuvant Holdings Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was 円17.860.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).

Please read Which price ratio outperforms the enterprise multiple?


Adjuvant Holdings Co EV-to-EBITDA Related Terms


Adjuvant Holdings Co EV-to-EBITDA Historical Data

* Premium members only.

The historical data trend for Adjuvant Holdings Co's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Adjuvant Holdings Co EV-to-EBITDA Chart

Adjuvant Holdings Co Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
EV-to-EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only 14.26 18.18 41.62 17.46 14.96

Adjuvant Holdings Co Semi-Annual Data
Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25 Mar26
EV-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 41.62 30.97 17.46 0.00 14.96

TSE:4929 vs PG, CL, EL: EV-to-EBITDA Comparison

For the Household & Personal Products subindustry, Adjuvant Holdings Co's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Adjuvant Holdings Co EV-to-EBITDA vs Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Adjuvant Holdings Co's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Adjuvant Holdings Co's EV-to-EBITDA falls into.


TSE:4929
59GF Score
Adjuvant Holdings Co Ltd TSE:4929
EV-to-EBITDA is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Adjuvant Holdings Co EV-to-EBITDA Calculation

Adjuvant Holdings Co's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=3815.936/260.383
=14.66

Adjuvant Holdings Co's current Enterprise Value is 円3,816 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Adjuvant Holdings Co's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 was 円260 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EV-to-EBITDA →
What does a EV-to-EBITDA of 14.66 mean?
Adjuvant Holdings Co (TSE:4929) has a EV-to-EBITDA of 14.66 as of Aug. 31, 2026. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Adjuvant Holdings Co. This is near median its historical median of 15.74. According to the industry distribution chart, Adjuvant Holdings Co ranks #1178 out of 1655 companies in the Consumer Packaged Goods industry, placing it in the top 71.2%.
Is Adjuvant Holdings Co's EV-to-EBITDA too high?
Adjuvant Holdings Co's current EV-to-EBITDA of 14.66 is near median its 10-year median of 15.74. The Consumer Packaged Goods industry median EV-to-EBITDA is 9.31. Adjuvant Holdings Co's value of 14.66 is 57.5% above this industry median. Based on the distribution chart, Adjuvant Holdings Co ranks #1178 out of 1655 companies in the Consumer Packaged Goods industry, which is below the industry midpoint. Overall, Adjuvant Holdings Co has a GF Score™ of 59/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Adjuvant Holdings Co's EV-to-EBITDA compare to PG and CL?
According to the Consumer Packaged Goods industry distribution chart, Adjuvant Holdings Co ranks #1178 out of 1655 companies for EV-to-EBITDA. This places Adjuvant Holdings Co in the lower half of its industry. The industry median EV-to-EBITDA is 9.31. Adjuvant Holdings Co's value of 14.66 is 57.5% above this benchmark. While the company's 10-year median is 15.74 vs. the industry median of 9.31, Adjuvant Holdings Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBITDA for a Consumer Packaged Goods company?
The median EV-to-EBITDA among Consumer Packaged Goods companies is 9.31, based on 1,655 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Adjuvant Holdings Co's current EV-to-EBITDA of 14.66 is 57.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBITDA mean?
A high EV-to-EBITDA can signal that a stock is expensive relative to its fundamentals. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Adjuvant Holdings Co. For the Consumer Packaged Goods industry, the median EV-to-EBITDA is 9.31 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Adjuvant Holdings Co's current EV-to-EBITDA is 14.66, which is near median its own 10-year median of 15.74. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Adjuvant Holdings Co stock overvalued right now?
Based on GuruFocus' analysis, Adjuvant Holdings Co (TSE:4929) is currently considered Fairly Valued. The stock's GF Value™ is 円730.77, compared to a current price of 円741.00 — trading 1.4% above its estimated fair value. The current EV-to-EBITDA is 14.66, which is near median its 10-year median of 15.74 and 57.5% above the Consumer Packaged Goods industry median of 9.31. Adjuvant Holdings Co's overall GF Score™ is 59/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBITDA calculated?
EV-to-EBITDA is calculated from a company's financial statements. For Adjuvant Holdings Co (TSE:4929), the current EV-to-EBITDA is 14.66 as of Aug. 31, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Adjuvant Holdings Co (TSE:4929) Overvalued in 2026?

Based on GuruFocus' analysis, Adjuvant Holdings Co stock appears to be overvalued. The current stock price of 円741.00 is trading 1.4% above its estimated GF Value™ of 円730.77. GuruFocus considers Adjuvant Holdings Co to be Fairly Valued.

Key valuation signals for TSE:4929:

  • EV-to-EBITDA: 14.66 (near median its 10-year median of 15.74)
  • GF Value™: 円730.77 vs. price of 円741.00 (1.4% above fair value)
  • GF Score™: 59/100 with 2 warning signs
  • Industry Position: 57.5% above the Consumer Packaged Goods median (#1178 of 1655)

No single metric tells the full story. See the TSE:4929 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Adjuvant Holdings Co Business Description

Address 5-5-5 Shimoyamatedori, Chuo-ku, Hyogo Prefecture, Kobe City, JPN, 650-0011
Adjuvant Holdings Co Ltd, formerly Adjuvant Cosme Japan Co Ltd is engaged in the research, development, production, and sale of cosmetics in Japan. It offers skin care products, including cleansing products, facial cleansers, lotions, beauty essences, masks, moisturizing creams, makeup bases, makeup, and body care products among other products.
59GF Score

Get the complete analysis for TSE:4929

EV-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円741.00
Price
円730.77
GF Value